To amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements.
Impact
If enacted, HB 8123 would grant the FDA additional authorities to seize dietary supplements that are non-compliant with the established definition of dietary supplements. It also modifies existing import exclusion criteria, allowing for stricter oversight of products that do not conform to the set standards. This change is aimed at ensuring that only safe and properly labeled dietary supplements are available to consumers, thus enhancing nutritional safety and public health.
Summary
House Bill 8123 aims to amend the Federal Food, Drug, and Cosmetic Act by establishing new prohibited acts concerning the introduction and delivery of dietary supplements that do not comply with the defined standards. This amendment would primarily enhance the regulatory framework governing dietary supplements, ensuring that all products marketed as such meet strict compliance requirements. The bill reflects an increasing concern over the safety and integrity of dietary supplements available in the market, which have surged in popularity over the years.
Contention
Notably, the bill may generate debate regarding the balance between consumer protection and the regulatory burden on dietary supplement manufacturers. Proponents argue that stricter regulations are essential to safeguard public health and prevent misleading marketing practices. Conversely, opponents may raise concerns about the potential for over-regulation, which could stifle innovation and limit consumer choices. The discussions around this bill could involve various stakeholders, including manufacturers, health advocates, and regulatory bodies, all vying to influence the final provisions of the bill.
A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products and foods for special dietary uses as qualified medical expenses.